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Purpose: To develop pH-sensitive controlled release formulation of clarithromycin in oil-entrapped 
calcium pectinate microgel bead.  
Methods:  Pectin-based oil-entrapped microgel beads were prepared by ionic gelation technique. The 
gel beads were formed instantly after adding the liquid formulation mixture dropwise into calcium 
chloride solution. The beads were optimized by coating with ethylcellulose solution and then evaluated 
for their diameter, floating lag time, encapsulation efficiency and drug release.    
Results: Particle size, encapsulation efficiency and buoyancy were significantly affected by the 
concentration of the polymer and calcium chloride .The formulation exhibited sustained release profile 
and was best fitted to the Peppas model with n < 0.45. Ethylcellulose-coated formulation batch, C16, was 
the most suitable controlled formulation with drug release of 65 ± 2.61 %  in 8 h. 
Conclusion: An ethylcellulose-coated formulation with potential for sustained delivery of clarithromycin 
in the acidic region of the gastrointestinal tract was successfully developed.  
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INTRODUCTION 
 
The oral route has attracted special attention 
for the delivery of anti infective agents that 
are needed to produce local action in the 
gastrointestinal tract. This route of 
administration usually shows high compliance 
by patients due to ease of administration.  
 
A search of the scientific and patent literature 
reveals an increased interest in novel dosage 
forms for the targeting of different parts of the 
gastrointestinal tract for drug retention at the 
site of action for a predetermined time [1,2]. 
This approach is especially most attractive for 
the delivery of anti-infective agents for the 
targeting of local microbial lesions inside 
gastrointestinal tract and promises to provide 
a more effective cure of such infectious 
lesions than conventional dosage forms. This 
is because a major problem frequently 
encountered with conventional oral dosage 
forms is the inability to localise drug release 
in the stomach and proximal portion of the 
small intestine [3,4]. Floating drug and 
bioadhesive drug delivery systems are widely 
used techniques for gastroretention [5,6]. 
 
Clarithromycin is a semi-synthetic macrolide 
antibiotic derived from erythromycin. It is 
primarily bacteriostatic and exerts its 
antimicrobial effect by the inhibition of protein 
synthesis on bacterial ribosome [7,8]. Pectin 
is a colloidal polygalacturonic acid in which 
some of the carboxylic groups are esterified 
with methyl groups. The main constituent of 
pectin is D-galectouronic acid [9,10]. This low 
methoxy polysaccharide polymer, with a 
degree of esterification < 50 %, can form rigid 
gels in the presence of calcium ions or other 
multivalent cations which crosslink the 
galacturonic acid chains of pectin to yield 
hydrogels that are stable at low pH. Pectin 
can reduce interfacial tension between an oil 
phase and a water phase and is efficient for 
the preparation of emulsions [11].  
 
The objective of this work was to develop a 
gastroretentive, multiple-unit, controlled 
release formulation of clarithromycin that 
would achieve continuous release of the drug 
in the gastric region and thus be useful for 







Clarithromycin was obtained as a gift from 
Ranbaxy Laboratories, Devash, India. Low-
methoxy pectin, with a degree of esterification of 
35 %, and ethyl cellulose, were obtained from 
S.D. Fine Chemicals, India. Light mineral oil and 
castor oil were supplied by Central Drug House, 
India. 
 
Preparation of calcium pectinate beads 
 
The gel beads were formulated using a 2
3
 
factorial design. The effect of concentration of 
the oils (castor and mineral oils), pectin and 
calcium chloride were fixed in the formulation as 
independent variables. The effect of the 
dependent variables in the formulation was 
investigated in terms of bead diameter, floating 
lag time and encapsulation efficiency. The 
composition of eighteen batches of the drug-
loaded calcium pectinate beads is given in 
Table 1. 
 
Table 1: Composition of drug-loaded calcium 








C1/M1 1.25 5 0.275 
C2/M2 1.25 10 0.275 
C3/M3 1.85 5 0.275 
C4/M4 1.25 5 0.450 
C5/M5 1.25 15 0.275 
C6/C6 1.85 5 0.450 
C7/C7 1.25 15 0.450 
C8/C8 1.85 10 0.450 
C9/C9 1.85 15 0.450 
 
Note: C and M are formulations containing castor oil and 
mineral oil, respectively; each formulation contained 
clathromycin 0.5 %w/v  
 
Oil-entrapped calcium pectinate gel beads 
were prepared by ionic gelation method.  The 
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drug was dispersed in varying concentrations 
of aqueous solution of pectin (1.25 - 1.85 %)  
with continuous stirring until a uniform 
dispersion containing 0.5 % of the drug was 
obtained. The mixture was emulsified with 
either mineral oil or castor oil using a 
Silverson emulsifier (Hicon, India) at a 
constant stirring rate of 500 rpm for 5 min. 
The resulting drug-loaded emulsion was 
dropped through a 21G syringe needle 
separately into 100 mL of 0.275 - 0.45 mol 
ml
-1
 of calcium chloride solution and stirred 
with a magnetic stirrer to improve the 
mechanical strength of the beads and to 
prevent their aggregation. Formation of small 
microgel beads of clarithromycin based on 
either castor oil (COB) or mineral oil (MOB) 
occurred after 5 min of curing. The beads 
were washed with distilled water, collected by 
filtration throughWhatman filter paper no. 1 
and dried in a tray dryer at 40 °C for 6 h.  
 
Coating of gel beads 
 
The selected gel bead formulations were 
coated with ethyl cellulose (EC) in a 2
2
 
factorial design (see Table 2) for 
optimization. The coating formulation was 5 – 
10 %w/v ethyl cellulose (EC) solution in 
acetone and coating time was 5 - 10 min. 
The gel beads (2 g) were placed in a 
fluidized bed dryer (TG 100, Retsch, 
Germany) and the fluidized beads were 
sprayed with the coating solution for a period 
of 5 or 10 min at an air inlet speed of 220 m/s 
at room temperature. The beads were dried 
at room temperature for a period of 24 h 
when the solvent evaporated, leaving a film 
coat on the gel beads. 
 
Size and morphology 
 
The particle size of the beads were 
determined in three sets using an optical 
microscope (Model BH-2, Olympus, Japan) 
fitted with a stage micrometer. Twenty dried 
beads were measured for the calculation of 
mean diameter. The external and internal 
morphology of the beads were studied by 
scanning electron microscopy (SEM). In this 
assessment, the beads were first coated with 
gold palladium under argon atmosphere 
using a gold sputter module in a high vacuum 
evaporator. The coated samples were then 
observed with SEM. 
 
In vitro floating study   
    
In vitro floating test was performed using a 
USP 24 dissolution apparatus II in 500 mL of 
phthalate buffer solution (pH 3.4) with the 
medium temperature kept at 37 ± 0.5 °C. The 
floating beads (1 g) were placed in the 
dissolution medium agitated with a paddle at 
50 rpm. After agitation, the beads that floated 
on the surface of the medium and those that 
settled down at the bottom of the flask were 
recovered separately. Lag time (the time 
taken for the beads to float at the surface of 
the medium) and floating behaviour were 
observed for up to 12 h [12]. 
 
Determination of drug-loading and 
encapsulation efficiency  
 
Accurately weighed (100 mg) grounded powder 
of beads was soaked in 100 ml phosphate buffer 
(pH 7.5) and allowed to disintegrating completely 
for 4 h [13]. The resulting dispersion was 
sonicated using a probe sonicator (UP 400 s, Dr. 
Hielscher GmbH, Germany) for 30 min and then 
filtered through a 0.45 µm filter. The polymeric 
debris was washed twice with fresh phosphate 
buffer to extract any adhered drug and drug 
content was determined spectrophotometrically 
at λmax of 353 nm against a constructed 
calibration curve. The encapsulation efficiency 
(EE) was calculated according to the relationship 
in Eq 1. 
 
EE (%) =  (C/T) x 100  ……………….……….  (1)     
 
where C is the calculated drug content and T 
is the theoretical drug content. 
 
In vitro drug release 
 
In vitro dissolution studies were performed for 
the gel beads using USP 24 dissolution test 
apparatus II (basket type) [13]. Accurately 
weighed 50 mg amount of the bead 
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(containing 19 – 21 mg of active drug) 
dropped in 900 ml of simulated gastric fluid 
(SGF, fasting state, pH 1.2; prepared by 
dissolving 2 g of sodium chloride, 3.2 g 
pepsin, and 6.8 ml of hydrochloric acid in 
double distilled water to 1 L), or fed state 
(phthalate buffer solution, pH 3.4) maintained 
at 37 ± 0.5 ºC and stirred at a speed of 50 
rpm. At different time intervals over a period 
of 8 h, a 10 mL aliquot of the medium was 
withdrawn and replenished with an equivalent 
volume of plain dissolution medium. The 
samples were filtered, suitably diluted and 
analyzed at a wavelength of 353 nm using a 
UV-visible spectrophotometer (Shimadzu). 
The drug release data were corrected for 
drug loss during sampling and degradation at 
acidic pH. All the tests were carried out in 
triplicate. Additionally, an experimental batch 
containing 10 mg clarithromycin and lactose 
(q.s.) filled into an empty capsule shell (#2) 
was used as a reference formulation.  
 
Kinetic release evaluation  
 
To investigate the mode of drug release from 
the microgel beads, the release data were 
analyzed with various release kinetic models 
(zero order, Higuchi and Korshmaer-Peppas) 
were applied to elucidate their mechanism of 
drug release in the fed state [14-16]. The 
analysis of the dissolution data was carried 
out using Eqs 2 – 4 for zero order, Higuchi 
and Korsemeyer-Peppas models, respect-
tively.  
 
   Mt = M0 + K0t …………………...……… (2) 
   Mt = M0 + KHt
0.5 
………………….…….. (3) 
   Korsemeyer-Peppas model: 
   Mt/M∞ = kt
n
 ……………………….……. (4) 
 
where Mt is the amount of drug dissolved in 
time t, M0 is the initial amount of drug, K0 is 
the zero order release constant and KH is the 
Higuchi rate constant. Mt/M∞ is the fraction of 
drug release at time t, k is the release rate 
constant, and n is the release exponent 
indicative of the mechanism of release. 
Statistical analysis 
 
The results were expressed as mean ± SD 
(standard deviation). Statistical evaluation of the 
data was performed using analysis of variance 
(ANOVA) and, depending on the outcome of 
ANOVA, Dunnett’s multiple comparison test 
was also applied. Statistically significant 
difference between the means of batches was 




The scanning electron micrographs (SEM) of 
the dried microgel beads, C6 and M6, are 
shown in Figure 1. Gel beads prepared from 
mineral oil (MOB) were white, translucent and 
rigid, while castor oil-based gel beads (COB) 
were off–white, translucent and elastic. 
 
 
                 
             1A                1B  
 
Figure 1: Scanning electron micrographs of dried 
beads of batch C6 (COB, 1A) and batch M6 (MOB, 
1B)  
 
The diameter of MOB varied between 1.24 ± 
0.60 and 1.46 ± 0.30 mm while that of COB 
was between 1.45 ± 0.80 and 1.80 ± 0.20 
mm. Floating lag time (the time taken for the 
beads to float at the surface of the medium) 
was 10 – 52 s and 16 -74 s for MOB and 
COB, respectively (Table 3).  
 
Encapsulation efficiency was highest for 
batch C6 (75.0 ± 0.8 %) and batch M6 (70.0 ± 
0.3 %) while drug content was 55.0 ± 1.3 % 
and 67.0 ± 1.3%, respectively, for the 
batches.   
 
In vitro drug release 
 
The dissolution data are shown in Fig 2. The 
results indicate that 90.1 ± 2.5 % of the pure 
drug (batch F) dissolved in 2 h in fasting state 
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(pH 1.2) while for the fed state (F2, pH 3.4), 
the figure was 87.5 ± 2.5 %. In 4h, drug 
release from batch C6 was 80.0 ± 2.4 % 
(fasting state) and from batch M6 76.0 ± 2.7 
% (fed state) in simulated gastric fluid (SGF). 
For the EC-coated beads (batch C61), a 
maximum dissolution efficiency of 65.5 % 
was attained in 8 h, as shown in Table 2. 
 
Table 2: Independent variables for ethyl cellulose-











C61 5 5 65.5 0.984 
C62 5 10 60.4 0.972 
C63 10 5 50.8 0.972 
C64 10 10 42.4 0.968 
DR = dissolution efficiency;  R
2
 = correlation coefficient 
 
 
Drug release from the optimized bead 
formulations C6 and M6 followed the Higuchi 
(R
2
 = 0.9841, n = 0.41) and Peppas models 
(R
2
 = 0.9827, n = 0.39), respectively. 
Correlation coefficient (R
2
) of the coated 
batches (see Table 2), based on zero order 




Spherical gel beads were formed instantaneously 
when emulsion was dropped into calcium 
chloride solutions. Gelation occurred due to 
intermolecular cross-linking between the divalent 
calcium ions and the negatively charged carboxyl 
groups of pectin. Pectin promoted the 
emulsification of the mixture of water and oil 
phases during homogenization and the resulting 
oil droplets were dispersed in calcium crosslinked 
network of the formulation. 
    



















































    2A          2B 
Figure 2: Comparative drug release profile for fasting states (2A)  (●=F2, ■ = C6, ∆ = M6); and fed state (2B)  
(▲= FC6, x = FM6, ○ = F); and for fed state of ethyl cellulose-coated beads (∆ = C63, X = C64) 
 
Formulation     Diameter (mm)      Lag time (s) 
Encapsulation  
efficiency (%) 
Drug content  
        (%) 
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The diameter of the beads increased 
significantly (p < 0.05) as polymer 
concentration increased; this could be 
attributed to the increase in the micro-
viscosity of the polymeric dispersion, 
eventually leading to the formation of larger 
beads. Larger size beads were also formed 
as the concentration of calcium chloride 
increased. This may be due to excess 
calcium ions causing possibly all the 
crosslinking sites in the polymer to be fully 
utilized and resulting in larger but weaker and 
flexible gel beads.  
 
Buoyancy is an important factor in sustained 
drug delivery to the gastric region. All the 
beads floated on simulated gastric fluid for up 
to 12 h. Increase in the calcium chloride 
content of the beads resulted in a decrease in 
floating lag time. due to increase in the 
porosity of the gel beads.  Floating lag time 
also rose as the concentration of oil in the 
formulation increased and this can be 
attributed to flocculation of the oil globules 
which might also have coalesced to produce 
large droplets.  
 
The encapsulation efficiency of the beads 
rose as polymer concentration increased due 
to the availability of excess polymer which 
ensured that the drug was optimally 
entrapped. On the other hand, encapsulation 
efficiency decreased with increase in calcium 
chloride concentration because excess Ca
2+
 
would have the effect of weakening the 
polymer gel structure and strength, thus 
leaving it more porous and limiting its 
capacity to trap the drug.  
 
Drug release from the beads (as shown in Fig 
2A) was characterized by an initial phase of 
rapid release (‘burst effect’) due to the 
presence of clarithromycin on the bead 
surface since the drug exhibits good solubility 
at low pH [17].. However, release thereafter 
slowed down due to the obstruction of drug 
diffusion by pectin - Ca
2+
 ions crosslinks. The 
release exponent (n) value of 0.045 suggests 
a diffusion-based release mechanism [18]. 
 
However, the dissolution profiles of the 
coated beads (batch C62, C62 ,C63 and C64) 
were best fitted to the  zero-order kinetic 
model (Fig 2B ) . Formulation batch C61 was 
considered the optimized gastroretentive 
controlled-release floating gel bead for 
clarithromycin, as it showed the lowest 




The developed oil-entrapped gel beads 
showed good floating and controlled drug 
release properties at simulated acid pH 
conditions of the stomach. Therefore, it may 
be capable of delivering clarithromycin to 
stomach sites, thus opening up the possibility 
of targeting the drug to gastric sites for the 
treatment of microbial infections such as that 
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